Neurocrine (NBIX)
NASDAQ:NBIX
US Market

Neurocrine (NBIX) Technical Analysis

Compare
1,359 Followers

Technical Sentiment

Overall Consensus
Strong Sell
0Bullish
0Neutral
13Bearish
Technical Analysis Consensus
Strong Sell
0Bullish
0Neutral
1Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Neurocrine’s (NBIX) Moving Averages Convergence Divergence (MACD) indicator is -2.53, suggesting Neurocrine is a Sell.
Neurocrine’s (NBIX) 20-Day exponential moving average is 110.18, while Neurocrine’s (NBIX) share price is $95.65, making it a Sell.
Neurocrine’s (NBIX) 50-Day exponential moving average is 117.27, while Neurocrine’s (NBIX) share price is $95.65, making it a Sell.

Neurocrine (NBIX) Pivot Points

Apr 06, 2025, 10:56 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
105.27
107.13
108.87
110.73
112.47
114.33
116.07
Fibonacci
107.13
108.51
109.36
110.73
112.11
112.96
114.33
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Neurocrine (NBIX) Moving Averages

Apr 06, 2025, 10:56 PM
Period
Simple
Exponential
MA5
104.89Sell
103.61Sell
MA10
109.78Sell
107.04Sell
MA20
109.91Sell
110.18Sell
MA50
120.68Sell
117.27Sell
MA100
126.54Sell
122.55Sell
MA200
128.90Sell
127.51Sell
Neurocrine’s (NBIX) 10-Day exponential moving average is 107.04, while Neurocrine’s (NBIX) share price is $95.65, making it a Sell.
Neurocrine’s (NBIX) 100-Day exponential moving average is 122.55, while Neurocrine’s (NBIX) share price is $95.65, making it a Sell.
Neurocrine’s (NBIX) stock price is $95.65 and Neurocrine’s (NBIX) 50-day simple moving average is 120.68, creating a Sell signal.
Neurocrine’s (NBIX) stock price is $95.65 and Neurocrine’s (NBIX) 100-day simple moving average is 126.54, creating a Sell signal.
Neurocrine’s (NBIX) stock price is $95.65 and Neurocrine’s (NBIX) 200-day simple moving average is 128.90, creating a Sell signal.

Neurocrine (NBIX) Technical Indicators

Apr 06, 2025, 10:56 PM
Name
Value
Implied Action
RSI (14)
33.67
Neutral
STOCH (9,6)
27.60
Neutral
STOCHRSI (14)
39.19
Neutral
MACD (12,26)
-2.53
Sell
ADX (14)
30.73
Neutral
Williams %R
-94.76
Buy
CCI (14)
-113.21
Buy
ATR (14)
3.23
-
Ultimate Oscillator
48.55
Neutral
ROC
-14.22
Sell
Neurocrine’s (NBIX) Relative Strength Index (RSI) is 33.67, creating a Neutral signal.
Neurocrine’s (NBIX) Trend Strength Indicator (ADX) is 30.73, creating a Neutral signal.
Neurocrine’s (NBIX) Commodity Channel Index (CCI) is -113.21, creating a Buy signal.
Neurocrine’s (NBIX) Price Rate of Change (ROC) is -14.22, creating a Sell signal.

FAQ

Is NBIX a Buy, Hold, or Sell?
Based on NBIX’s technical indicators, NBIX is a Strong Sell.
    What is NBIX’s RSI (14)?
    NBIX’s RSI (14) is 33.67, which suggests NBIX is a Neutral.
      What is NBIX’s MACD?
      NBIX’s MACD is -2.53, which suggests NBIX is a Sell.
        What is NBIX’s 5-day moving average?
        NBIX’s 5-day moving average is 104.89, which suggests NBIX is a Sell.
          What is NBIX’s 20-day moving average?
          NBIX 20-day moving average is 109.91, which suggests NBIX is a Sell.
            What is NBIX’s 50-day moving average?
            NBIX’s 50-day moving average is 120.68, which suggests NBIX is a Sell.
              What is NBIX’s 200-day moving average?
              NBIX’s 200-day moving average is 128.90, which suggests NBIX is a Sell.
                What is NBIX’s Williams % R (14)?
                NBIX’s Williams % R (14) is -94.76, which suggests NBIX is a Buy.
                  What is NBIX’s CCI (14)?
                  NBIX’s CCI (14) is -113.21, which suggests NBIX is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis